Sfoglia per Autore
Long-term suppression of viral replication in HIV-related lymphoma survivors: a case-control study
2010-01-01 Spagnuolo, V; Galli, L; Travi, G; Cossarini, F; Salpietro, S; Gianotti, N; Cinque, P; Bossolasco, S; Vinci, C; Lazzarin, A; Castagna, A
High plasma levels of parathyroid hormone (PTH) are associated with an increased cardiovascular risk among HIV-infected subjects
2010-01-01 Spagnuolo, V; Galli, L; Salpietro, S; Vinci, C; Cossarini, F; Travi, G; Rubinacci, A; Mignogna, G; Cernuschi, M; Bossolasco, S; Lazzarin, A; Castagna, A
Transient Elastometry And Other Non Invasive Tools To Assess Liver Fibrosis In HIV-Monoinfected Persons On Antiretroviral Drugs
2010-01-01 Hamid, Hasson; Giulia, Gallotta; Lucy, Porrino; Laura, Galli; Castagna, Antonella; Stefania, Salpietro; Giulia, Morsica; Sabrina, Bagaglio; Lazzarin, Adriano; UBERTI FOPPA, Caterina
Immune Reconstitution is Associated with Delayed Occurrence and Longer Survival after Hodgkin Disease in HIV-infected Patients
2010-01-01 Cossarini, F; Galli, L; Spagnolo, V; Sampietro, S; Travi, G; Bossolasco, S; Gianotti, N; Cinque, P; Lazzarin, A; Castagna, A
Liver histology in HIV/hepatitis C-coinfected and HCV-monoinfected patients with persistently normal alanine aminotransferases
2010-01-01 Sagnelli, C; Uberti-Foppa, C; Pasquale, G; Coppola, N; Albarello, L; Masiello, A; Doglioni, C; Lazzarin, A; Sagnelli, E.
Prevalence of type 2 diabetes mellitus and its predictive factors in Italy: a comparison between HIV-infected and uninfected subjects
2010-01-01 Galli, L; Salpietro, S; Pellicciotta, G; Galliani, A; Piatti, Pm; Hasson, H; Guffanti, M; Gianotti, N; Bigoloni, A; Lazzarin, A; Castagna, A
Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism
2010-01-01 Siccardi, Marco; D'Avolio, Antonio; Nozza, Silvia; Simiele, Marco; Baietto, Lorena; Stefani, Francesca Romana; Moss, Darren; Kwan, Wai san; Castagna, Antonella; Lazzarin, Adriano; Calcagno, Andrea; Bonora, Stefano; Back, David; Di Perri, Giovanni; Owen, Andrew
Durability of a novel salvage therapy in R5 HIV-infected patients: maraviroc, raltegravir, etravirine
2010-01-01 Nozza, S; Bigoloni, A; Galli, L; Gianotti, N; Pogliaghi, M; Cossarini, F; Salpietro, S; Galli, A; Della Torre, L; Tambussi, G; Lazzarin, A; Castagna, A
LONG TERM CD4 RECOVERY IN FULLY SUPPRESSED SUBJECTS TREATED WITH FIRST LINE HAART IS INFLUENCED BY TIME TO REACH UNDETECTABILITY
2011-01-01 Travi, G; Salpietro, S; Pizzocolo, C; Galli, L; Spagnuolo, V; Cossarini, F; Gianotti, N; Nozza, S; Lazzarin, A; Castagna, A
Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage
2011-01-01 Svicher, V; Alteri, C; Artese, A; Zhang, Jm; Costa, G; Mercurio, F; D'Arrigo, R; Alcaro, S; Palu, G; Clementi, Massimo; Zazzi, M; Andreoni, M; Antinori, A; Lazzarin, Adriano; Ceccherini Silberstein, F; Perno, Cf
Longitudinal evaluation of occult Hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption
2011-01-01 Bagaglio, S; Bianchi, G; Danise, A; Porrino, L; UBERTI FOPPA, Caterina; Lazzarin, Adriano; Castagna, Antonella; Morsica, G.
HIV protease inhibitors: Present and future
2011-01-01 Pizzocolo, Cecilia; Castagna, A; Lazzarin, Adriano
Pharmacokinetics of the raltegravir/maraviroc/etravirine combination
2011-01-01 Calcagno, Andrea; Nozza, Silvia; Bonora, Stefano; Castagna, Antonella; de Requena Daniel, Gonzalez; D'Avolio, Antonio; Lazzarin, Adriano; Di Perri, Giovanni
Maraviroc Can Improve Lipid Profiles in Dyslipidemic Patients with HIV: Results from the MERIT Trial
2011-01-01 Macinnes, A.; Lazzarin, Adriano; Di Perri, G.; Sierra Madero, J. G.; Aberg, J.; Heera, J.; Rajicic, N.; Goodrich, J.; Mayer, H.; Valdez, H.
Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patients
2011-01-01 Gianotti, N.; Visco, F.; Galli, L.; Barda, B.; Piatti, P.; Salpietro, S.; Bigoloni, A.; Vinci, C.; Nozza, S.; Gallotta, G.; Lazzarin, A.; Castagna, A.
CHANGES IN PATIENT-REPORTED OUTCOMES DURING THE SENSE TRIAL: FIRST-LINE TREATMENT WITH 2 NRTIS PLUS ETRAVIRINE OR EFAVIRENZ
2011-01-01 Castagna, A; Lazzarin, A; Carosi, G; Andreoni, M; Orkin, C; Streinu-Cercel, A; Erscoiu, S; Nelson, M; Hill, A; van Delft, Y; Marks, S
Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic-clinical Management of HIV-1 Infected Persons
2011-01-01 Antinori, Andrea; Marcotullio, Simone; Ammassari, Adriana; Andreoni, Massimo; Angarano, Gioacchino; Carosi, Giampiero; Cinque, Paola; Monforte Antonella, D'Arminio; Di Perri, Giovanni; Ensoli, Barbara; Ferrazzi, Enrico; Galli, Massimo; Mastroianni, Claudio; Matteelli, Alberto; Mazzotta, Francesco; Moroni, Mauro; Palu, Giorgio; Puoti, Massimo; Puro, Vincenzo; Rizzardini, Giuliano; Sagnelli, Evangelista; Suter, Fredy; Vella, Stefano; Lazzarin, A; for the Italian HIV Guidelines Working, Group
Integrase and Fusion Inhibitors Transmitted Drug Resistance in Naive Patients With Recent Diagnosis of HIV-1 Infection
2011-01-01 Cossarini, F; Boeri, E; Canducci, F; Salpietro, S; Bigoloni, A; Galli, L; Spagnuolo, Vincenzo; Castagna, Antonella; Clementi, Massimo; Lazzarin, Adriano; Gianotti, N.
Durability and safety of a novel salvage therapy in R5-tropic HIV-infected patients: Maraviroc, raltegravir, etravirine
2011-01-01 Nozza, S.; Galli, L.; Bigoloni, A.; Nicola, G.; Pogliaghi, M.; Cossarini, F.; Salpietro, S.; Galli, A.; Torre, L. D.; Tambussi, G.; Lazzarin, A.; Castagna, A.
Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption
2011-01-01 Canducci, F; Barda, B; Ceresola, E; Spagnuolo, Vincenzo; Sampaolo, M; Boeri, E; Nozza, S; Cossarin, F; Galli, A; Gianotti, N; Castagna, Antonella; Lazzarin, Adriano; Clementi, Massimo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Long-term suppression of viral replication in HIV-related lymphoma survivors: a case-control study | 1-gen-2010 | Spagnuolo, V; Galli, L; Travi, G; Cossarini, F; Salpietro, S; Gianotti, N; Cinque, P; Bossolasco, S; Vinci, C; Lazzarin, A; Castagna, A | |
| High plasma levels of parathyroid hormone (PTH) are associated with an increased cardiovascular risk among HIV-infected subjects | 1-gen-2010 | Spagnuolo, V; Galli, L; Salpietro, S; Vinci, C; Cossarini, F; Travi, G; Rubinacci, A; Mignogna, G; Cernuschi, M; Bossolasco, S; Lazzarin, A; Castagna, A | |
| Transient Elastometry And Other Non Invasive Tools To Assess Liver Fibrosis In HIV-Monoinfected Persons On Antiretroviral Drugs | 1-gen-2010 | Hamid, Hasson; Giulia, Gallotta; Lucy, Porrino; Laura, Galli; Castagna, Antonella; Stefania, Salpietro; Giulia, Morsica; Sabrina, Bagaglio; Lazzarin, Adriano; UBERTI FOPPA, Caterina | |
| Immune Reconstitution is Associated with Delayed Occurrence and Longer Survival after Hodgkin Disease in HIV-infected Patients | 1-gen-2010 | Cossarini, F; Galli, L; Spagnolo, V; Sampietro, S; Travi, G; Bossolasco, S; Gianotti, N; Cinque, P; Lazzarin, A; Castagna, A | |
| Liver histology in HIV/hepatitis C-coinfected and HCV-monoinfected patients with persistently normal alanine aminotransferases | 1-gen-2010 | Sagnelli, C; Uberti-Foppa, C; Pasquale, G; Coppola, N; Albarello, L; Masiello, A; Doglioni, C; Lazzarin, A; Sagnelli, E. | |
| Prevalence of type 2 diabetes mellitus and its predictive factors in Italy: a comparison between HIV-infected and uninfected subjects | 1-gen-2010 | Galli, L; Salpietro, S; Pellicciotta, G; Galliani, A; Piatti, Pm; Hasson, H; Guffanti, M; Gianotti, N; Bigoloni, A; Lazzarin, A; Castagna, A | |
| Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism | 1-gen-2010 | Siccardi, Marco; D'Avolio, Antonio; Nozza, Silvia; Simiele, Marco; Baietto, Lorena; Stefani, Francesca Romana; Moss, Darren; Kwan, Wai san; Castagna, Antonella; Lazzarin, Adriano; Calcagno, Andrea; Bonora, Stefano; Back, David; Di Perri, Giovanni; Owen, Andrew | |
| Durability of a novel salvage therapy in R5 HIV-infected patients: maraviroc, raltegravir, etravirine | 1-gen-2010 | Nozza, S; Bigoloni, A; Galli, L; Gianotti, N; Pogliaghi, M; Cossarini, F; Salpietro, S; Galli, A; Della Torre, L; Tambussi, G; Lazzarin, A; Castagna, A | |
| LONG TERM CD4 RECOVERY IN FULLY SUPPRESSED SUBJECTS TREATED WITH FIRST LINE HAART IS INFLUENCED BY TIME TO REACH UNDETECTABILITY | 1-gen-2011 | Travi, G; Salpietro, S; Pizzocolo, C; Galli, L; Spagnuolo, V; Cossarini, F; Gianotti, N; Nozza, S; Lazzarin, A; Castagna, A | |
| Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage | 1-gen-2011 | Svicher, V; Alteri, C; Artese, A; Zhang, Jm; Costa, G; Mercurio, F; D'Arrigo, R; Alcaro, S; Palu, G; Clementi, Massimo; Zazzi, M; Andreoni, M; Antinori, A; Lazzarin, Adriano; Ceccherini Silberstein, F; Perno, Cf | |
| Longitudinal evaluation of occult Hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption | 1-gen-2011 | Bagaglio, S; Bianchi, G; Danise, A; Porrino, L; UBERTI FOPPA, Caterina; Lazzarin, Adriano; Castagna, Antonella; Morsica, G. | |
| HIV protease inhibitors: Present and future | 1-gen-2011 | Pizzocolo, Cecilia; Castagna, A; Lazzarin, Adriano | |
| Pharmacokinetics of the raltegravir/maraviroc/etravirine combination | 1-gen-2011 | Calcagno, Andrea; Nozza, Silvia; Bonora, Stefano; Castagna, Antonella; de Requena Daniel, Gonzalez; D'Avolio, Antonio; Lazzarin, Adriano; Di Perri, Giovanni | |
| Maraviroc Can Improve Lipid Profiles in Dyslipidemic Patients with HIV: Results from the MERIT Trial | 1-gen-2011 | Macinnes, A.; Lazzarin, Adriano; Di Perri, G.; Sierra Madero, J. G.; Aberg, J.; Heera, J.; Rajicic, N.; Goodrich, J.; Mayer, H.; Valdez, H. | |
| Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patients | 1-gen-2011 | Gianotti, N.; Visco, F.; Galli, L.; Barda, B.; Piatti, P.; Salpietro, S.; Bigoloni, A.; Vinci, C.; Nozza, S.; Gallotta, G.; Lazzarin, A.; Castagna, A. | |
| CHANGES IN PATIENT-REPORTED OUTCOMES DURING THE SENSE TRIAL: FIRST-LINE TREATMENT WITH 2 NRTIS PLUS ETRAVIRINE OR EFAVIRENZ | 1-gen-2011 | Castagna, A; Lazzarin, A; Carosi, G; Andreoni, M; Orkin, C; Streinu-Cercel, A; Erscoiu, S; Nelson, M; Hill, A; van Delft, Y; Marks, S | |
| Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic-clinical Management of HIV-1 Infected Persons | 1-gen-2011 | Antinori, Andrea; Marcotullio, Simone; Ammassari, Adriana; Andreoni, Massimo; Angarano, Gioacchino; Carosi, Giampiero; Cinque, Paola; Monforte Antonella, D'Arminio; Di Perri, Giovanni; Ensoli, Barbara; Ferrazzi, Enrico; Galli, Massimo; Mastroianni, Claudio; Matteelli, Alberto; Mazzotta, Francesco; Moroni, Mauro; Palu, Giorgio; Puoti, Massimo; Puro, Vincenzo; Rizzardini, Giuliano; Sagnelli, Evangelista; Suter, Fredy; Vella, Stefano; Lazzarin, A; for the Italian HIV Guidelines Working, Group | |
| Integrase and Fusion Inhibitors Transmitted Drug Resistance in Naive Patients With Recent Diagnosis of HIV-1 Infection | 1-gen-2011 | Cossarini, F; Boeri, E; Canducci, F; Salpietro, S; Bigoloni, A; Galli, L; Spagnuolo, Vincenzo; Castagna, Antonella; Clementi, Massimo; Lazzarin, Adriano; Gianotti, N. | |
| Durability and safety of a novel salvage therapy in R5-tropic HIV-infected patients: Maraviroc, raltegravir, etravirine | 1-gen-2011 | Nozza, S.; Galli, L.; Bigoloni, A.; Nicola, G.; Pogliaghi, M.; Cossarini, F.; Salpietro, S.; Galli, A.; Torre, L. D.; Tambussi, G.; Lazzarin, A.; Castagna, A. | |
| Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption | 1-gen-2011 | Canducci, F; Barda, B; Ceresola, E; Spagnuolo, Vincenzo; Sampaolo, M; Boeri, E; Nozza, S; Cossarin, F; Galli, A; Gianotti, N; Castagna, Antonella; Lazzarin, Adriano; Clementi, Massimo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile